Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002052113-25-002989·AGIOS PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
Agios Pharmaceuticals Inc
Common Stock · CUSIP: 00847X104
Event date: 2025-06-30
- Filing-level shares
- 4,513,170
- Percent of class
- 7.8%
- BlackRock, Inc.
Shares: 4,513,170 · Class: 7.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-002989
- Form type
- SCHEDULE 13G/A
- Filer
- AGIOS PHARMACEUTICALS, INC.
- CIK
- CIK 1439222
- Filed
- Jul 17, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership